Six unrelated families with genetically determined structural variants of apo A-I were found in the course of an electrophoretic screening program for apo A-I variants in dried blood samples of newborns. The following structural variations were identified by the combined use of HPLC, time-of-flight secondary ion mass spectrometry (TOF-SIMS), and automated gas phase sequencing: Pro3----Arg (1x), Pro4----Arg (1x), and Pro165----Arg (4x). All variant carriers were heterozygous for their mutant of apo A-I. Subjects heterozygous for apo A-I(Pro165----Arg) (n = 12) were found to exhibit lower mean values for apo A-I (109 +/- 16 mg/dl) and HDL cholesterol (37 +/- 9 mg/dl) than unaffected family members (n = 9): 176 +/- 41 and 64 +/- 18 mg/dl, respectively (P less than 0.001). In 9 of 12 apo A-I(Pro165----Arg) variant carriers the concentrations of apo A-I were below the fifth percentile of sex-matched controls. By two-dimensional immunoelectrophoresis as well as by densitometry the relative concentration of the variant apo A-I in heterozygous carriers of apo A-I(Pro165----Arg) was determined to account for only 30% of the total plasma apo A-I mass instead of the expected 50%. Thus, the observed apo A-I deficiency may be largely a consequence of the decreased concentration of the variant apo A-I. In the case of the apo A-I(Pro3----Arg) mutant, densitometry of HDL apolipoproteins demonstrated a distinctly increased concentration of the variant proapo A-I relative to normal proapo A-I. This phenomenon was not observed in the apo A-I(Pro4----Arg) mutant or in other mutants. This suggests that the interspecies conserved proline residue in position 3 of mature apo A-I is functionally important for the regular enzymatic conversion of proapo A-I to mature apo A-I.
A von Eckardstein, H Funke, A Henke, K Altland, A Benninghoven, G Assmann
Title and authors | Publication | Year |
---|---|---|
High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives
MP Adorni, N Ronda, F Bernini, F Zimetti |
Cells | 2021 |
HDL Dysfunction Caused by Mutations in apoA-I and Other Genes that are Critical for HDL Biogenesis and Remodeling
A Chroni, D Kardassis |
Current medicinal chemistry | 2019 |
Structural Insights into High Density Lipoprotein: Old Models and New Facts
V Gogonea |
Frontiers in pharmacology | 2016 |
Reducing protein oxidation in low-flow electrospray enables deeper investigation of proteoforms by top down proteomics
K Kim, PD Compton, TK Toby, PM Thomas, JT Wilkins, RK Mutharasan, NL Kelleher |
EuPA Open Proteomics | 2015 |
Case report: A novel apolipoprotein A-I missense mutation apoA-I (Arg149Ser)Boston associated with decreased LCAT activation and cellular cholesterol efflux
P Anthanont, BF Asztalos, E Polisecki, B Zachariah, EJ Schaefer |
Journal of Clinical Lipidology | 2015 |
Mining the genome for lipid genes
JA Kuivenhoven, RA Hegele |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2014 |
Mutation mapping of apolipoprotein A-I structure assisted with the putative cholesterol recognition regions
AD Dergunov |
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics | 2013 |
Population-based resequencing of APOA1 in 10,330 individuals: spectrum of genetic variation, phenotype, and comparison with extreme phenotype approach
CL Haase, R Frikke-Schmidt, BG Nordestgaard, A Tybjærg-Hansen |
PLoS genetics | 2012 |
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz |
Protein Engineering for Therapeutics Part B | 2012 |
Population-Based Resequencing of APOA1 in 10,330 Individuals: Spectrum of Genetic Variation, Phenotype, and Comparison with Extreme Phenotype Approach
CL Haase, R Frikke-Schmidt, BG Nordestgaard, A Tybjærg-Hansen, MI McCarthy |
PLoS genetics | 2012 |
Apolipoprotein Mimetic Peptides: Mechanisms of Action as Anti-atherogenic Agents
DO Osei-Hwedieh, M Amar, D Sviridov, AT Remaley |
Pharmacology & Therapeutics | 2010 |
The HDL Handbook
NJ Hime |
The HDL Handbook | 2010 |
High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease
EJ Schaefer |
2010 | |
Handbook of Genomics and the Family
KP Tercyak |
2010 | |
Analysis of Opioid and Amyloid Peptides Using Time-of-Flight Secondary Ion Mass Spectrometry
S Solé-Domènech, B Johansson, M Schalling, J Malm, P Sjövall |
Analytical Chemistry | 2010 |
Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency
L Pisciotta, R Miccoli, A Cantafora, L Calabresi, P Tarugi, P Alessandrini, GB Bon, G Franceschini, C Cortese, S Calandra, S Bertolini |
Atherosclerosis | 2003 |
The Effects of Altered Apolipoprotein A-I Structure on Plasma HDL Concentration
MG Sorci-Thomas, MJ Thomas |
Trends in Cardiovascular Medicine | 2002 |
Enhanced fractional catabolic rate of apo A-I and apo A-II in heterozygous subjects for apo A-IZaragoza (L144R)
D Recalde, W Velez-Carrasco, F Civeira, A Cenarro, D Gomez-Coronado, JM Ordovas, M Pocovi |
Atherosclerosis | 2001 |
Characterization of the Maturation of Human Pro-apolipoprotein A-I in an in Vitro Model
LE Pyle, D Sviridov, NH Fidge |
Biochemistry | 2001 |
GENETICS OFLIPOPROTEINABNORMALITIESASSOCIATED WITHCORONARYHEARTDISEASESUSCEPTIBILITY
JL Breslow |
Annual Review of Genetics | 2000 |
Evidence of Linkage of Familial Hypoalphalipoproteinemia to a Novel Locus on Chromosome 11q23
EN Kort, DG Ballinger, W Ding, SC Hunt, BR Bowen, V Abkevich, K Bulka, B Campbell, C Capener, A Gutin, K Harshman, M McDermott, T Thorne, H Wang, B Wardell, J Wong, PN Hopkins, M Skolnick, M Samuels |
The American Journal of Human Genetics | 2000 |
Single Repeat Deletion in ApoA-I Blocks Cholesterol Esterification and Results in Rapid Catabolism of Δ6 and Wild-type ApoA-I in Transgenic Mice
MG Sorci-Thomas, M Thomas, L Curtiss, M Landrum |
The Journal of biological chemistry | 2000 |
Apolipoprotein A-I: structure–function relationships
PG Frank, YL Marcel |
Journal of lipid research | 2000 |
In vivo kinetics of human apolipoprotein A-I variants in rabbits
Saku, von Eckardstein, Zhang, Liu, Jimi, Ou, Ohta, Assmann, Arakawa |
European Journal of Clinical Investigation | 1999 |
Fast C18 solid-phase desalting/delipidation of the human serum apolipoproteins for matrix-assisted laser desorption ionization and electrospray ionization mass spectrometric analysis
LK Watkins, PV Bondarenko, DC Barbacci, S Song, SL Cockrill, DH Russell, RD Macfarlane |
Journal of Chromatography A | 1999 |
A Novel Mutant, ApoA-I Nichinan (Glu235→0), Is Associated With Low HDL Cholesterol Levels and Decreased Cholesterol Efflux From Cells
H Han, J Sasaki, A Matsunaga, H Hakamata, W Huang, M Ageta, T Taguchi, T Koga, M Kugi, S Horiuchi, K Arakawa |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
Multiple dysfunctions of two apolipoprotein A-I variants, apoA-I(R160L)Oslo and apoA-I(P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers
U Daum, TP Leren, C Langer, A Chirazi, P Cullen, PH Pritchard, G Assmann, A von Eckardstein |
Journal of lipid research | 1999 |
Postprandial responses of plasma lipids and lipoproteins in subjects with apoA-I(Lys107→0)
M Tilly-Kiesi, AH Lichtenstein, J Rintarahko, MR Taskinen |
Atherosclerosis | 1998 |
In vivo metabolism of apo A-I and apo A-II in subjects with apo A-I(Lys107→0) associated with reduced HDL cholesterol and Lp(AI w AII) deficiency
M Tilly-Kiesi, CJ Packard, J Kahri, C Ehnholm, J Shepherd, MR Taskinen |
Atherosclerosis | 1997 |
The replacement of arginine by cysteine at residue 151 in Apolipoprotein A-I produces a phenotype similar to that of Apolipoprotein A-I Milano
E Bruckert, A Eckardstein, H Funke, I Beucler, H Wiebusch, G Turpin, G Assmann |
Atherosclerosis | 1997 |
The Carboxyl-terminal Hydrophobic Residues of Apolipoprotein A-I Affect Its Rate of Phospholipid Binding and Its Association with High Density Lipoprotein
M Laccotripe, SC Makrides, A Jonas, VI Zannis |
The Journal of biological chemistry | 1997 |
Apolipoprotein A-I Fin: Dominantly Inherited Hypoalphalipoproteinemia Due to a Single Base Substitution in the Apolipoprotein A-I Gene
HE Miettinen, H Gylling, TA Miettinen, J Viikari, L Paulin, K Kontula |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Subjects With ApoA-I(Lys 107 →0) Exhibit Enhanced Fractional Catabolic Rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI With AII)
M Tilly-Kiesi, AH Lichtenstein, JM Ordovas, G Dolnikowski, R Malmström, MR Taskinen, EJ Schaefer |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Apolipoprotein A-I FIN (Leu159→Arg) Mutation Affects Lecithin: Cholesterol Acyltransferase Activation and Subclass Distribution of HDL but Not Cholesterol Efflux From Fibroblasts
HE Miettinen, M Jauhiainen, H Gylling, S Ehnholm, A Palomäki, TA Miettinen, K Kontula |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I
TP Leren, KS Bakken, U Daum, L Ose, K Berg, G Assmann, A von Eckardstein |
Journal of lipid research | 1997 |
Identification of two apolipoprotein variants, A-I Karatsu (Tyr 100 → His) and A-I Kurume (His 162 → Gin)
K Moriyama, J Sasaki, A Matsunaga, Y Takada, M Kagimoto, K Arakawa |
Clinical Genetics | 1996 |
Identification of Two Apolipoprotein Variants, A-I Kaho (Asp 51^|^rarr;Val) and A-I Lys 107 Deletion
K Moriyama, J Sasaki, A Matsunaga, K Arakawa |
Journal of Atherosclerosis and Thrombosis | 1996 |
Important Aspects concerning the Quantification of Biomolecules by Time-of-Flight Secondary-Ion Mass Spectrometry
DC Muddiman, AJ Nicola, A Proctor, DM Hercules |
Applied Spectroscopy | 1996 |
Compound Heterozygosity for a Structural Apolipoprotein A-I Variant, Apo A-I(L141R) Pisa , and an Apolipoprotein A-I Null Allele in Patients With Absence of HDL Cholesterol, Corneal Opacifications, and Coronary Heart Disease
R Miccoli, A Bertolotto, R Navalesi, L Odoguardi, A Boni, J Wessling, H Funke, H Wiebusch, A von Eckardstein, G Assmann |
Circulation | 1996 |
Mechanisms for the modulation of membrane bilayer properties by amphipathic helical peptides
RM Epand, Y Shai, JP Segrest, GM Anantharamiah |
Biopolymers | 1995 |
Structural models of human apolipoprotein A-I
C Brouillette |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1995 |
Genetically determined absence of HDL-cholesterol and coronary atherosclerosis
R Navalesi, R Miccoli, L Odoguardi, H Funke, A Eckardstein, H Wiebusch, G Assmann |
The Lancet | 1995 |
The genetic determinants of plasma cholesterol and response to diet
SE Humphries, RE Peacock, PJ Talmud |
Baillière's Clinical Endocrinology and Metabolism | 1995 |
Signal sorting by G-protein-linked receptors
G Milligan |
Advances in pharmacology (San Diego, Calif.) | 1995 |
Screening for naturally occurring apolipoprotein A-I variants: apo A-I(?K107) is associated with low HDL-cholesterol levels in men but not in women
JR Nofer, A Eckardstein, H Wiebusch, W Weng, H Funke, H Schulte, E Khler, G Assmann |
Human Genetics | 1995 |
ApoA-I Helsinki (Lys 107 →0) Associated With Reduced HDL Cholesterol and LpA-I:A-II Deficiency
M Tilly-Kiesi, Z Qiuping, S Ehnholm, J Kahri, S Lahdenperä, C Ehnholm, MR Taskinen |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Homozygous Tangier disease and cardiovascular disease
C Serfaty-Lacrosniere, F Civeira, A Lanzberg, P Isaia, J Berg, ED Janus, MP Smith, PH Pritchard, J Frohlich, RS Lees, GF Barnard, JM Ordovas, EJ Schaefer |
Atherosclerosis | 1994 |
Vascular Endothelium
MA Gimbrone, MI Cybulsky, N Kume, T Collins, N Resnick |
Annals of the New York Academy of Sciences | 1994 |
A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells
Y Huang, A Eckardstein, S Wu, N Maeda, G Assmann |
Proceedings of the National Academy of Sciences | 1994 |
Deletion of the propeptide of apolipoprotein A-I impairs exit of nascent apolipoprotein A-I from the endoplasmic reticulum
RS McLeod, C Robbins, A Burns, Z Yao, PH Pritchard |
Biochemical Journal | 1994 |
Characterization of two new human apolipoprotein A-I variants: Apolipoprotein A-I Tsushima (Trp-108 → Arg) and A-I Hita (Ala-95→ Asp)
A Keiichi, S Jun, M Akira, T Yoichi, M Kengo, H Kazuko, A Kikuo |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1994 |
Hypercatabolism of lipoprotein-free apolipoprotein A-I in HDL-deficient mutant chickens
SA Schreyer, LK Hart, AD Attie |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
Genetic factors in coronary heart disease
U Goldbourt, U de Faire, K Berg |
1994 | |
The application of molecular biology techniques to the diagnosis of hyperlipidaemia and other risk factors for cardiovascular disease
SE Humphries |
Clinica Chimica Acta | 1993 |
In vivo conversion of recombinant human proapolipoprotein AI (rh-Met-proapo AI) to apolipoprotein AI in rabbits
K Saku, R Liu, K Ohkubo, H Bai, K Hirata, K Yamamoto, Y Morimoto, K Yamada, K Arakawa |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1993 |
Structural and functional properties of natural and chemical variants of apolipoprotein A-I
A Jonas, AV Eckardstein, L Churgay, WW Mantulin, G Assmann |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1993 |
Advances in Human Genetics 21
H Harris, K Hirschhorn |
1993 | |
Human Apolipoprotein Mutants III
CR Sirtori, G Franceschini, BH Brewer |
1993 | |
Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165–>Arg)
A von Eckardstein, G Castro, I Wybranska, N Theret, P Duchateau, N Duverger, JC Fruchart, G Ailhaud, G Assmann |
The Journal of biological chemistry | 1993 |
Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations
H Paul-Hayase, M Rosseneu, D Robinson, JP Bervliet, JP Deslypere, SE Humphries |
Human Genetics | 1992 |
Cellular and Molecular Biology of Atherosclerosis
AM Gotto |
1992 | |
In vivo metabolism of a mutant apolipoprotein, apoA-IIowa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis
DJ Rader, RE Gregg, Meng, , LA Zech, Benson, HB Brewer |
Journal of lipid research | 1992 |
Transgenic mice expressing human apolipoprotein A-I have sera with modest trypanolytic activity in vitro but remain susceptible to infection by Trypanosoma brucei brucei
JS Owen, MP Gillett, TE Hughes |
Journal of lipid research | 1992 |
Apolipoprotein genes and atherosclerosis
JL Breslow |
The Clinical Investigator | 1992 |
Analysis of familial hypoalphalipoproteinemia syndromes
J Frohlich, PH Pritchard |
Molecular and Cellular Biochemistry | 1992 |
A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities
H Funke, A Eckardstein, PH Pritchard, M Karas, JJ Albers, G Assmann |
Journal of Clinical Investigation | 1991 |
Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia
A Eckardstein, H Holz, M Sandkamp, W Weng, H Funke, G Assmann |
Journal of Clinical Investigation | 1991 |
HDL and atherosclerosis: An update
JT Gwynne |
Clinical Cardiology | 1991 |
DNA Polymorphisms as Disease Markers
DJ Galton, G Assmann |
1991 | |
Characterization of a new human apolipoprotein A-I Yame by direct sequencing of polymerase chain reaction-amplified DNA
Y Takada, J Sasaki, M Seki, S Ogata, Y Teranishi, K Arakawa |
Journal of lipid research | 1991 |
Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants
A Jonas, A von Eckardstein, KE Kézdy, A Steinmetz, G Assmann |
Journal of lipid research | 1991 |
Site-specific methionine sulfoxide formation is the structural basis of chromatographic heterogeneity of apolipoproteins A-I, C-II, and C-III
A von Eckardstein, M Walter, H Holz, A Benninghoven, G Assmann |
Journal of lipid research | 1991 |
A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy
WC Nichols, RE Gregg, HB Brewer, MD Benson |
Genomics | 1990 |
Hypercholesterolemia, Hypocholesterolemia, Hypertriglyceridemia, in Vivo Kinetics
CL Malmendier, P Alaupovic, HB Brewer |
1990 | |
Advances in Human Genetics
H Harris, K Hirschhorn |
1990 | |
Spontaneous high density lipoprotein deficiency syndrome associated with a Z-linked mutation in chickens
F Poernama, SA Schreyer, JJ Bitgood, ME Cook, AD Attie |
Journal of lipid research | 1990 |
Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure
A von Eckardstein, H Funke, M Walter, K Altland, A Benninghoven, G Assmann |
The Journal of biological chemistry | 1990 |